A Delaware Chancery Court judge dismissed allegations that Synthes did not patiently shop or gain the highest price for Johnson & Johnson's $21.3 billion acquisition of the company, according to a
Bloomberg Businessweek report.
Synthes shareholders filed a lawsuit against the company, claiming it made the transaction to quickly come up with funds for Synthes chairman and controlling shareholder Hansjoerg Wyss' retirement.
Judge Leo Strine tossed out these allegations, citing lack of evidence to support their accusations.
More Articles on Orthopedic Devices:
FH Orthopedics Wins FDA Approval for Complete Shoulder Prosthesis System
5 More Things to Know About Spine Surgery
Johnson & Johnson Recalls All Unused Custom Orthopedic Implants 
